Skip to main content

Innovent Biologics Inc (IVBXF)

Sector
Healthcare
Industry
Biotechnology
Last price
$10.91
As of

Kresmion compiles this page from IVBXF's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Innovent Biologics Inc/ADR (IVBXF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and no SEC filing for the company is on record.

As of . Source: SEC EDGAR filings for IVBXF. Method and limitations.

COMPANY DOSSIER

See the full IVBXF dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for IVBXF on one page. Preview it with sample data, then open it live with a free account.

Preview the IVBXF dossier

Active events for IVBXF

  • mediumEarnings above estimates

    Q2-2026: Beat consensus by 98.2%, EPS $0.95 vs $0.4794 estimate

  • mediumEarnings above estimates

    Q4-2023: Beat consensus by 59.6% - EPS $-0.206 vs $-0.51 estimate

  • mediumEarnings above estimates

    Q2-2024: Beat consensus by 61.2% - EPS $-0.099 vs $-0.255 estimate

  • mediumEarnings above estimates

    Beat consensus by 59.6% - EPS $-0.206 vs $-0.51 estimate

  • mediumEarnings above estimates

    Beat consensus by 61.2% - EPS $-0.099 vs $-0.255 estimate

FREE, NO ACCOUNT

Every event on IVBXF, as it fires

You are seeing 5 of 7 events recorded on IVBXF since 2026-05-30.

The five above landed across 3 days. The other 2 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

More data on IVBXF

Cite this data

Kresmion counts the managers it follows that reported a non-option position in IVBXF on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on IVBXF in the last 180 days.

Upstream: SEC EDGAR filings for IVBXF

Kresmion, "Innovent Biologics Inc/ADR (IVBXF) institutional holdings and SEC filings", data as of 2026-09-29, https://kresmion.com/research/IVBXF. Upstream data: SEC EDGAR filings for IVBXF.

Link to this data (HTML):

<a href="https://kresmion.com/research/IVBXF">Innovent Biologics Inc/ADR (IVBXF) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow IVBXF on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to IVBXF for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the IVBXF dossier
Share

The IVBXF intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.